Alzprotect SAS
www.alzprotect.comAlzprotect is a biopharmaceutical company that develops drug candidates, from their discovery to clinical trials, for the treatment of neurodegenerative diseases including Alzheimer’s disease (AD) and tauopathies such as Progressive Supranuclear Palsy (PSP).
Read more
Alzprotect is a biopharmaceutical company that develops drug candidates, from their discovery to clinical trials, for the treatment of neurodegenerative diseases including Alzheimer’s disease (AD) and tauopathies such as Progressive Supranuclear Palsy (PSP).
Read more
Country
City (Headquarters)
Loos
Industry
Employees
1-10
Founded
2007
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Board Member
Email ****** @****.comPhone (***) ****-****Chief Medical Officer
Email ****** @****.comPhone (***) ****-****Chief Security Officer / Chief of Development
Email ****** @****.comPhone (***) ****-****Chief Scientific Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(1)
Reach decision makers at Alzprotect SAS
Free credits every month!
Alzprotect SAS FAQ
Loos, France
Biotechnology Research
